Business Context and Reporting Period
This Form 6-K filing by Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) covers the month of July 2026, with the report dated July 30, 2026. The filing discloses inside information regarding regulatory authorization and the Board of Directors' resolution to initiate a new share buyback program aimed at reducing the company's share capital.
Key Financial Metrics and Capital Actions
The filing focuses on capital management rather than operational financial performance. Key metrics include:
- Buyback Authorization: The European Central Bank authorized a maximum aggregate buyback amount of EUR 2,000 million, valid until July 16, 2027.
- Capital Impact: The full EUR 2,000 million has been deducted from BBVA's individual and consolidated Common Equity Tier 1 (CET1) capital as of the authorization date.
- First Tranche Details:
- Maximum cash amount: EUR 1,000 million.
- Maximum number of shares: 483,221,729.
- Execution period: August 5, 2026, to October 9, 2026 (subject to extension for excluded days).
The filing text does not provide values for revenue, profit, cash flow, operating margins, debt levels, or liquidity ratios.
Material Changes
The primary material change is the initiation of a new share repurchase scheme following regulatory approval. The Board resolved to execute the first tranche of EUR 1,000 million immediately, marking a significant deployment of capital to reduce share capital. No other material changes to operations or financial standing are detailed in this specific filing.
Guidance, Outlook, and Risks
Management Commentary: The Board exercised authority delegated by the Annual Shareholders' Meeting (March 20, 2026) to reduce share capital. The program is designed to be executed in several tranches.
Risks and Contingencies:
- Suspension/Termination: BBVA reserves the right to temporarily suspend or early terminate the buyback program or the first tranche if circumstances make it advisable.
- Trading Constraints: Purchases are subject to market abuse regulations, limiting daily acquisitions to no more than 25% of the average daily volume on each trading venue.
- Execution Delays: The end date of the first tranche may be postponed by one trading day for each "Excluded Day" (e.g., market closures, trading suspensions, or prices below nominal value), up to a maximum extension of October 23, 2026.
The filing does not provide specific financial guidance, earnings outlook, or discussion of unusual items.
Investor Verification Checklist
- Verify the impact of the EUR 2,000 million deduction on BBVA's current CET1 capital ratio in the most recent quarterly report.
- Monitor the execution progress of the first tranche (EUR 1,000 million) starting August 5, 2026, via subsequent regulatory announcements.
- Confirm the total number of shares outstanding post-buyback to assess dilution or accretion effects.
- Review the Annual Shareholders' Meeting minutes from March 20, 2026, for the full scope of the delegated authority.